Becton, Dickinson and Company (LON:0R19)
195.29
+1.20 (0.62%)
Dec 5, 2025, 5:01 PM BST
LON:0R19 Revenue
In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B USD with 8.24% growth. Becton, Dickinson and Company had revenue of $5.89B in the quarter ending September 30, 2025, with 8.35% growth.
Revenue
$21.84B
Revenue Growth
+8.24%
P/S Ratio
2.56
Revenue / Employee
$303.33K
Employees
72,000
Market Cap
41.55B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 21.84B | 1.66B | 8.24% |
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Becton, Dickinson and Company News
- 1 day ago - Noteworthy Thursday Option Activity: COHR, RGTI, BDX - Nasdaq
- 1 day ago - Ex-Dividend Reminder: Becton, Dickinson, Nicolet Bankshares and UnitedHealth Group - Nasdaq
- 2 days ago - BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories - PRNewsWire
- 3 days ago - BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes - PRNewsWire
- 3 days ago - Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
- 3 days ago - BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BDX Stock News - GuruFocus
- 6 days ago - Best Dividend Aristocrats For December 2025 - Seeking Alpha
- 10 days ago - Beyond the Balance Sheet: What SWOT Reveals About Becton Dickinson & Co (BDX) - GuruFocus